At Acadia, we remain deeply committed to providing important new therapies to patients and delivering value for our stockholders. Our Investor Center is designed to provide you with convenient access to company information.

Recent News

ATLANTA & SAN DIEGO --(BUSINESS WIRE)--Oct. 14, 2020-- The Lewy Body Dementia Association (LBDA) and Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today an exclusive partnership on the production and release of a disease education adaptation of the new film Robin’s Wish © , a documentary
  Partnership provides educational resources on navigating cognitive changes to people with Parkinson’s and their care partners  Among the estimated 6 million people worldwide with Parkinson’s, many say thinking and memory changes — ranging from mild cognitive impairment to dementia — are among the
SAN DIEGO --(BUSINESS WIRE)--Oct. 1, 2020-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Elizabeth (Betsy) Garofalo , M.D. to its Board of Directors. Dr. Garofalo is a biopharma executive with more than 25 years of experience in global clinical development and
There are currently no events scheduled.